Soluble fms-like tyrosine kinase-1 and atherosclerosis in chronic kidney disease.
Level V
Where this comes from
- Record sourced from PubMed, PMID 24487364.
- Also identified by DOI 10.1038/ki.2013.402.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Vascular endothelial growth factor (VEGF) and its cousins, such as placental growth factor, have moved into the daily clinical arena. One-step-removed regulators, such as the VEGF splice variant soluble fms-like tyrosine kinase-1 (sFlt-1), now clinically emerge. sFlt-1 keeps our corneas 'clean.' However, sFlt-1 could also cause disease, such as preeclampsia. The report by Matsui et al. on ApoE and sFlt-1 gene-deleted mice could foster important subsequent research. We are limited only by our imaginations.
Medical subject headings
- Atherosclerosis
- Renal Insufficiency, Chronic
- Vascular Endothelial Growth Factor Receptor-1